Abiopharma

🔍 Yoo Chue-San (Executive)

Company: TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD (TSM)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Acquired 51 shares of Common Shares (2330.TW) at $73.31 per share (Direct)
  Date: 2026-08-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 6,641.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Holds 0 shares of Common Shares (2330.TW) (Direct)
  Date: 2026-08-07 | Code: H | shares_owned_after: 1,797,614.00
• Holds 0 shares of Common Shares (2330.TW) (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: By LTI Trust | shares_owned_after: 7,036.00 | Footnotes: F4
• Holds 0 shares of Common Shares (2330.TW) (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 219,924.00
• Holds 0 shares of Common Shares (2330.TW) (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: By Yuding Investment Co., Ltd. | shares_owned_after: 851,908.00

Footnotes:

• F1: Common Shares purchased by the administrator of the issuer's Employee Stock Purchase Plan ("ESPP") on behalf of the filer pursuant to terms predetermined by the issuer.
• F2: The price was translated from the average purchase price of NT$2,367.1117 in New Taiwan dollars, at the rate of NT$32.288 to US$1.
• F3: Common Shares purchased and held under the issuer's Employee Stock Purchase Plan ("ESPP").
• F4: Represents Common Shares purchased by a trust with cash received under the issuer's Long-Term Incentive ("LTI") Bonus Plan, over which the filer has obtained investment control.